Navigation Links
AnazaoHealth Announces Full Continued Cooperation with FDA to Promote Quality Assurance and Patient Safety
Date:3/8/2013

TAMPA, Fla., March 8, 2013 /PRNewswire/ -- Staying true to its commitment to patient safety, specialty pharmacy AnazaoHealth Corporation has announced continued investment in quality assurance measures, including full cooperation with the U.S. Food and Drug Administration (FDA) to assess and improve quality practices. The specialty pharmacy has been in the compounding pharmacy business for more than 15 years, and more than 95 percent of its business remains patient-specific.  Because it does not mass-produce medications and fills patient-specific prescriptions from licensed physicians, the pharmacy is not regulated by FDA Manufacturing Guidelines – instead adhering to USP<797> standards developed specifically for the compounding pharmacy industry and adopted into law by the Florida Board of Pharmacy.  Despite this, AnazaoHealth is fully cooperating with the FDA, who inspected AnazaoHealth alongside state agency inspectors who found no deficiencies.  The pharmacy continues to seek other internal and external audits to ensure the highest standards of quality and patient safety. 

"While the debate is being waged on what standards are most appropriate for the compounding pharmacy industry, we remain focused on promoting quality assurance of the highest standard, no matter what," said Jacob J. Beckel , chairman and CEO, AnazaoHealth.  "That is why in addition to meeting or exceeding all standards of our regulating body -- the Florida Board of Pharmacy -- we are also implementing measures above-and-beyond, including actions based on some of the observations by the FDA."

Throughout its history, AnazaoHealth has regularly sought both internal and external audits performed by industry experts to evaluate and guide its industry-leading quality assurance program, helping the company to meet and / or exceed all USP <797> sterile compounding and USP <795> non-sterile compounding standards.  AnazaoHealth was among the first in the country to be awarded accreditation from the Pharmacy Compounding Accreditation Board (PCAB) in 2008, and remains accredited today. Pharmacists serve as Corporate Quality Director, Corporate Quality Manager, and as divisional Clinical Quality Managers.  The company's sterile compounding process involves no fewer than four different validation checks prior to completion of an order and makes extensive use of bar code technology, lessening chance of human error.  AnazaoHealth is also planning further investment in enhancing its level of sterility testing, addressing some of the recommendations made during the recent FDA inspection.

"We know how important this is – this is the safety of our patients, and patient care is at the heart of our pharmacy," said David Joseph , R.Ph, director of pharmacy, quality and regulatory compliance, AnazaoHealth. "We are proud of our quality program, and we will continue to make improvements to uphold the highest standards in the pharmacy industry."

About AnazaoHealth
AnazaoHealth Corporation, a specialty pharmacy, has been in the compounding pharmacy business for over fifteen years, focusing on patient specific preparations serving the nuclear medicine, pain management and custom pharmacy markets, as well as providing drugs used in clinical trials.  More information is available at www.anazaohealth.com


'/>"/>
SOURCE AnazaoHealth Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cellular Dynamics Announces Presentations at the Society of Toxicologys 52nd Annual Meeting Demonstrating the Expanding Impact of iPSC-Derived Human Cells on Toxicology Assay Development
2. Zimmer Announces 11% Increase in Quarterly Dividend for First Quarter of 2013
3. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
4. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
5. China Botanic Pharmaceutical Inc. Announces Acceptance of its Plan of Compliance by NYSE MKT LLC
6. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
7. MiMedx Announces 2012 Results
8. CCS Medical Announces Agreement with LifeScan
9. HUYA Bioscience Announces Partnership With Shanghai Zhangjiang Biotech Pharmaceutical Base
10. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
11. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Impax Laboratories Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  Alopexx Oncology, LLC announced data from a Phase ... (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal antibody. ... cells as Rituxan and maintains the activities of both ... in tumor targeting, engagement of the immune system, and ... the study (abstract #95954) were presented at the 58 ...
(Date:12/6/2016)... -- Radioisotopes are radioactive isotopes having an unstable balance ... nuclear research reactor or by using cyclotron. These isotopes ... gamma when changed to a stable nature. The gamma ... in medical diagnostics. In this field, the radiation is ... functioning. Radiotherapy is also used to treat some life-threatening ...
(Date:12/6/2016)... Homozygous Familial Hypercholesterolemia (HoFH) - ... Global Markets Direct,s latest Pharmaceutical and Healthcare ... – Pipeline Review, H2 2016, provides an ... (Metabolic Disorders) pipeline landscape. Homozygous familial ... caused due to mutation from both parents. ...
Breaking Medicine Technology:
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... ... “The Road To Restoration”: an informative and enlightening book for those who ... of hands. “The Road To Restoration” is the creation of published author, Thomas Fitzhugh ... ring that you could reach out for, and grab, on the old carousels. ...
(Date:12/7/2016)... ... 2016 , ... “Fred Rides a Train” allows readers to tag along on ... Rides a Train” is the creation of published author, Janet Morrison, who has been ... Michigan. The "Fred, the Dog" series is her first attempt at writing for children. ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg ... the International Probiotic Association’s Washington DC workshop on November 2nd. The conference was ... dialog regarding probiotic dietary supplement regulations. , Dr. Leyer spoke about two ...
(Date:12/6/2016)... ... 06, 2016 , ... People with Parkinson’s disease and cognitive ... type of MRI, according to a study appearing online in the journal Radiology. ... characterized by tremors or trembling and stiffness in the limbs, impaired balance and ...
Breaking Medicine News(10 mins):